Molulife 200 Capsule is a prescription-only medicine containing the active ingredient Molnupiravir (200mg) in a delayed-release formulation. This medicine is indicated for the treatment of mild to moderate COVID-19 in adults and pediatric patients aged 5 and older. Molulife 200 Capsule is a ribonucleoside-based inhibitor that works by directly targeting the SARS-CoV-2 virus, thereby reducing the viral load and alleviating symptoms. The medicine is designed to be taken orally once daily for five days, with the first dose taken within 5 days of symptom onset. Molulife 200 Capsule is contraindicated in patients who have not tested positive for COVID-19 or those who have severe COVID-19. The most common adverse reactions include diarrhea, headache, nausea, and vomiting. Molulife 200 Capsule is not a substitute for other therapies and should be used in combination with standard of care, including antiviral therapy, if recommended. As with all prescription medicines, patients should consult with their healthcare provider to determine the appropriate dosage and duration of treatment.

Dosage & How to Use